The Journal of Organic Chemistry
Note
mmol), and toluene-d8 (500 μL) under argon atmosphere. The
Notes
suspension was shaken and this time was taken as time zero. Enamine
The authors declare no competing financial interest.
1
formation was monitored by NMR. After 10 min, the H NMR spectra
35
1
showed total conversion to enamine 21 (lit. ): H NMR (400 MHz,
ACKNOWLEDGMENTS
toluene-d ) δ ppm 7.21−7.10 (m, 5 H), 6.84 (d, 1 H, J = 13.9 Hz),
8
■
6
.93 (m, 1 H), 5.14 (d, 1H, J = 13.9 Hz), 2.83 (m, 4 H), 1.50−1.36
The research was supported in part by The National Institute
of Industrial Technology (INTI), Consejo Nacional de
(
m, 4H). At this point, 100 μL of a 0.6 M (toluene-d ) fresh stock
8
solution of nitrostyrene (16) was added. After the mixture was shaken,
NMR recordings were run until no further changes were observed in
the reaction profile.
́
́ ́
Investigacion Cientifica y Tecnologica (CONICET), Chem-
essentia SRL, and University of Siena. Authors acknowledge
Ing. Leandro Santos for NMR support.
Cyclobutane 22, 1-(2-Nitro-3,4-diphenylcyclobutyl)-
1
pyrrolidine. H NMR (400 MHz, toluene-d ) δ (ppm) 7.17−6.76
8
(
(
(
m, 10 H), 4.85 (dd, 1 H, J = 7.2, 8.7 Hz), 3.88−3.91 (m, 1 H), 3.65
REFERENCES
■
dd, 1 H, J = 7.2, 8.7 Hz), 2.98 (m, 1 H), 2.31 (m, 4 H), 1.50−1.36
m, 4 H)); 13C NMR (100 MHz, toluene-d ) δ (ppm) 140.33 (C),
(
1) Betancort, J. M.; Barbas, C. F. Org. Lett. 2001, 3, 3737−3740.
8
1
4
38.9 (C), 132.9−126.3(CH), 84.8 (CH), 69.8 (CH), 51.6 (CH ),
(2) List, B.; Pojarliev, P.; Martin, H. J. Org. Lett. 2001, 3, 2423−2525.
(3) Bertelsen, S.; Jørgensen, K. A. Chem. Soc. Rev. 2009, 38, 2178−
2189.
2
8.9 (CH), 47.7 (CH), 26.6 (CH ).
2
Product Enamine 18, (E,Z)-1-(4-Nitro-2,3-diphenylbut-1-
enyl)pyrrolidine. E/Z mixtures were observed during the course of
(4) Enders, D.; Wang, C.; Yang, X.; Raabe, G. Adv. Synth. Catal.
2010, 352, 2869−2874.
1
the reaction. H NMR signals were assigned based on 2D spectra.
1
Compound 18a: H NMR (400 MHz, toluene-d ) δ (ppm) 7.42−6.89
(5) Ishikawa, H.; Honma, M.; Hayashi, Y. Angew. Chem., Int. Ed.
2011, 50, 2824−2827.
8
(
m, 10 H), 6.88 (s, 1 H), 4.28 (m, 1 H), 3.90 (m, 2 H), 2.15 (m, 4 H),
13
1
.15−1.36 (m, 4 H); C NMR (100 MHz, toluene-d ) δ (ppm) 141.5
́
(6) Palomo, C.; Vera, S.; Mielgo, A.; Gomez-Bengoa, E. Angew.
8
(
5
C), 140.4 (C), 132.9−126.3(CH), 137.0 (C), 108.9 (C), 79.3 (CH ),
Chem., Int. Ed. 2006, 45, 5984−5987.
2
1
2.51 (CH), 52.49 (CH ), 26.2 (CH ). Compound 18b: H NMR
(7) Lalonde, M. P.; Chen, Y.; Jacobsen, E. N. Angew. Chem., Int. Ed.
2006, 45, 6366−6370.
2
2
(
4
4
400 MHz, toluene-d ) δ (ppm) 7.42−6.89 (m, 10 H), 6.07 (s, 1 H),
8
.37 (m, 2 H), 4.13 (dd, 1 H, J = 4.7, 9.7 Hz), 2.56 (m, 4 H), 1.19 (m,
(8) Sulzer-Mosse,
2007, 3123−3135.
́
(9) Seebach, D.; Golinski, J. Helv. Chim. Acta 1981, 64, 1413−1423.
́
S.; Alexakis, A. Chem. Commun. (Cambridge, U. K.)
H); 13C NMR (100 MHz, toluene-d ) δ (ppm) 141.7 (C), 138.2
8
(
(
C), 132.9−126.3 (CH), 133.3 (C), 108.9 (C), 80.5 (CH ), 67.5
2
CH), 52.1 (CH ), 26.3 (CH ).
(10) Moberg, C. Angew. Chem., Int. Ed. 2013, 52, 2160−2162.
(11) Seebach, D.; Sun, X.; Ebert, M.; Schweizer, W. B.; Purkayastha,
N.; Beck, A. K.; Duschmale, J.; Wennemers, H.; et al. Helv. Chim. Acta
2013, 96, 799−852.
2
2
Reaction between Hexanal (19) and Nitrostyrene (16). A NMR
tube was charged with hexanal (7.4 μL, 0.06 mmol), MS (4 Å),
pyrrolidine (5 μL, 0.06 mmol), and toluene-d (500 μL) under argon
8
atmosphere. The suspension was shaken and this time was taken as
́
(12) Bures, J.; Armstrong, A.; Blackmond, D. G. J. Am. Chem. Soc.
time zero. Enamine formation was monitored by NMR. After 10 min,
2011, 133, 8822−8825.
1
the H NMR spectra (400 MHz, toluene-d ) δ ppm 6.11 (d, 1 H, J =
(13) Bures, J.; Armstrong, A.; Blackmond, D. G. Chem. Sci. 2012, 3,
8
́
1
2
3
3.6 Hz), 4.18 (dt, 1 H, J = 13.6, 7.0 Hz), 2.79 (t, 4 H, J = 6.4 Hz),
.05−2.15 (m, 2 H) 1.48−1.57 (m, 4 H) 1.36−1.46 (m, 4 H), 0.94 (t,
H, J = 7.1 Hz) showed total conversion to enamine 23; and 100 μL
1
(
273−1277.
14) Ishikawa, H.; Suzuki, T.; Hayashi, Y. Angew. Chem., Int. Ed.
2
009, 48, 1304−1307.
of a 0.6 M (toluene-d ) fresh stock solution of nitrostyrene was added.
The suspension was shaken and this time was taken as time zero. H
8
(15) Zhu, S.; Yu, S.; Wang, Y.; Ma, D. Angew. Chem., Int. Ed. 2010,
9, 4656−4660.
1
4
(
NMR spectra were recorded until no further changes were. The
acquired spectra were processed manually to obtain the concentration
of each species during the reaction.
16) Wong, J. C.; Tang, G.; Wu, X.; Liang, C.; Zhang, Z.; Guo, L.;
Peng, Z.; Zhang, W.; Lin, X.; Wang, Z.; Mei, J.; Chen, J.; Zhao, R.; She,
J.; Ren, Y.; Xu, C.; Chen, D.; Cai, J.; Shan, S.; Pan, D.; et al. J. Med.
Chem. 2012, 55, 8903−8925.
Cyclobutane 24, 1-(2-Butyl-4-nitro-3-phenylcyclobutyl)-
1
pyrrolidine. H NMR (400 MHz, toluene-d ) δ (ppm) 7.13−7.01
8
(17) Qin, D.; Norton, B.; Liao, X.; Knox, A. N.; Fang, Y.; Lee, J.;
(
m, 5 H), 4.68 (dd, 1 H, J = 6.8, 8.6 Hz), 3.36 (t, 1 H, J = 8.9 Hz), 3.17
t, 1 H, J = 7.86 Hz), 2.48−2.29 (m, 4 H), 2.02 (m, 1 H), 1.51 (m, 4
H), 1.37 (m, 2 H), 1.08 (m, 4 H), 0.74 (m, 3 H).
Dreabit, J. C.; Christensen, S. B.; Benowitz, A. B. Peptide Deformylase
Inhibitors. WO2009061879 A1, May 14, 2009.
(
(18) Bissantz, C.; Jablonski, P.; Knust, H.; Koblet, A.; Limberg, A.;
Nettekoven, M.; Ratni, H.; Riemer, C. Pyrrolidine Dreivatives as NK2
Receptor Antagonists. U.S. Patent US20090312327 A1, December 17,
ASSOCIATED CONTENT
■
2
009.
19) Andrey, O.; Alexakis, A.; Tomassini, A.; Bernardinelli, G. Adv.
Synth. Catal. 2004, 346, 1147−1168.
20) Laars, M.; Ausmees, K.; Uudsemaa, M.; Tamm, T.; Kanger, T.;
*
S
Supporting Information
(
(
Lopp, M. J. Org. Chem. 2009, 74, 3772−3775.
X-ray crystallographic data for 13a and 17a (CIF)
Tables of reaction optimization, NMR spectra of new
compounds and intermediates, and X-ray experimental
(
21) Alza, E.; Pericas
̀
, M. A. Adv. Synth. Catal. 2009, 351, 3051−3056.
(22) Zhang, X.-J.; Liu, S.-P.; Li, X.-M.; Yan, M.; Chan, A. S. C. Chem.
Commun. (Cambridge, U. K.) 2009, 833−835.
(23) Rogozinska-Szymczak, M.; Mlynarski, J. Eur. J. Org. Chem. 2015,
015, 6047−6051.
24) Patora-Komisarska, K.; Benohoud, M.; Ishikawa, H.; Seebach,
́
2
(
AUTHOR INFORMATION
D.; Hayashi, Y. Helv. Chim. Acta 2011, 94, 719−745.
(25) Hayashi, Y.; Gotoh, H.; Hayashi, T.; Shoji, M. Angew. Chem., Int.
Ed. 2005, 44, 4212−4215.
(26) Mukherjee, S.; Yang, J. W.; Hoffmann, S.; List, B. Chem. Rev.
Present Address
Pharmaceutical Development and Manufacturing Sciences,
Janssen Pharmaceutica, Turnhoutseweg 30, 2340 Beerse,
Belgium.
2
(
007, 107, 5471−5569.
⊥
27) Gu, L.; Zhao, G. Adv. Synth. Catal. 2007, 349, 1629−1632.
(28) Li, Y.; Liu, X.-Y.; Zhao, G. Tetrahedron: Asymmetry 2006, 17,
2034−2039.
E
J. Org. Chem. XXXX, XXX, XXX−XXX